Target intelligence / Profile preview

Epstein-Barr Virus

Molecular classification: Virus, dsDNA Virus, Herpesviridae, Lymphocryptovirus

Overview

Epstein-Barr virus is a ubiquitous human herpesvirus that establishes lifelong infection predominantly within B lymphocytes. It plays significant roles not only in common self-limited illnesses like mononucleosis but also contributes to oncogenesis through sophisticated molecular mechanisms involving both protein-coding genes and regulatory non-coding RNAs.

Other names: Human herpesvirus 4HHV-4

Biological functions

InfectionReplicationLatencyImmune evasionOncogenesis

Disease associations

Infectious mononucleosisBurkitt lymphomaHodgkin lymphomaNasopharyngeal carcinomaAutoimmune diseasesOther chronic conditions

Safety considerations

No vaccine availableNo antiviral treatment to eliminate latent infectionOncogenic potential

Beyond the preview

Go deeper on Epstein-Barr Virus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epstein-Barr Virus.

Explore the full profile